Literature DB >> 24980984

Time to treatment-door-to-balloon time is not everything.

C J Terkelsen1.   

Abstract

International guidelines for the management of patients with ST-elevation myocardial infarction (STEMI) recommend various performance measures to monitor the quality of STEMI systems of care. Door-to-balloon (D2B) time (arrival at hospital to percutaneous coronary intervention, PCI) and overall health care system delay (first medical contact to reperfusion) are acknowledged as valuable performance measures when treating patients with primary percutaneous coronary intervention (PPCI). However, there is confusion regarding the exact definition of these performance measures, and moreover system delay and PCI-related delay (the extra delay acceptable to perform PPCI instead of fibrinolysis) are often used synonymously, which add confusion when considering reperfusion strategy. The present paper calls for a consensus regarding the use and definition of objective performance measures when treating patients with STEMI, and exemplifies why it is insufficient just to focus on D2B time.

Entities:  

Mesh：

Year:  2014        PMID： 24980984     DOI： 10.1007/s00059-014-4125-y

Source DB:  PubMed          Journal:  Herz        ISSN： 0340-9937            Impact factor:   1.443


  24 in total

1.  Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis.

Authors:  L J Morrison; P R Verbeek; A C McDonald; B V Sawadsky; D J Cook
Journal:  JAMA       Date:  2000 May 24-31       Impact factor: 56.272

2.  Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial.

Authors:  Philippe Gabriel Steg; Eric Bonnefoy; Sylvie Chabaud; Frédéric Lapostolle; Pierre-Yves Dubien; Pascal Cristofini; Alain Leizorovicz; Paul Touboul
Journal:  Circulation       Date:  2003-11-17       Impact factor: 29.690

3.  Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase.

Authors:  Duane S Pinto; Paul D Frederick; Anjan K Chakrabarti; Ajay J Kirtane; Edward Ullman; Andre Dejam; Dave P Miller; Timothy D Henry; C Michael Gibson
Journal:  Circulation       Date:  2011-11-07       Impact factor: 29.690

4.  Timely PCI for STEMI--still the treatment of choice.

Authors:  Deepak L Bhatt
Journal:  N Engl J Med       Date:  2013-03-10       Impact factor: 91.245

5.  Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1993-08-05       Impact factor: 91.245

6.  Impact of community intervention to reduce patient delay time on use of reperfusion therapy for acute myocardial infarction: rapid early action for coronary treatment (REACT) trial. REACT Study Group.

Authors:  J R Hedges; H A Feldman; V Bittner; R J Goldberg; J Zapka; S K Osganian; D M Murray; D G Simons-Morton; A Linares; J Williams; R V Luepker; M S Eisenberg
Journal:  Acad Emerg Med       Date:  2000-08       Impact factor: 3.451

7.  Reduction of treatment delay in patients with ST-elevation myocardial infarction: impact of pre-hospital diagnosis and direct referral to primary percutanous coronary intervention.

Authors:  Christian Juhl Terkelsen; Jens Flensted Lassen; Bjarne Linde Nørgaard; Jens Christian Gerdes; Steen Hvitfeldt Poulsen; Kristoffer Bendix; Jens Peter Ankersen; Liv Bjørn-Hansen Gøtzsche; Frode Kirketerp Rømer; Torsten Toftegaard Nielsen; Henning Rud Andersen
Journal:  Eur Heart J       Date:  2005-01-31       Impact factor: 29.983

8.  An evaluation of the results of media and educational campaigns designed to shorten the time taken by patients with acute myocardial infarction to decide to go to hospital.

Authors:  M B Blohm; M Hartford; B W Karlson; R V Luepker; J Herlitz
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

9.  System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention.

Authors:  Christian Juhl Terkelsen; Jacob Thorsted Sørensen; Michael Maeng; Lisette Okkels Jensen; Hans-Henrik Tilsted; Sven Trautner; Werner Vach; Søren Paaske Johnsen; Leif Thuesen; Jens Flensted Lassen
Journal:  JAMA       Date:  2010-08-18       Impact factor: 56.272

10.  2012 ESC STEMI guidelines and reperfusion therapy: Evidence base ignored, threatening optimal patient management.

Authors:  Christian Juhl Terkelsen; Duane S Pinto; Holger Thiele; Peter Clemmensen; Kjell Nikus; Jens Flensted Lassen; David Hildick-Smith; Evald Høj Christiansen; Jens Aarøe; Hans-Henrik Tilsted Hansen; Goran Stankovic; Anders Junker; Georgios Sianos; Göran Olivecrona; Hans Erik Bøtker; Charles Michael Gibson; Eric Boersma
Journal:  Heart       Date:  2013-06-17       Impact factor: 5.994
View more
  2 in total

1.  ST-Segment Elevation Myocardial Infarction: Door to Balloon Time Improvement Project.

Authors:  Saad Al Bugami; Jamilah Alrahimi; Abdullah Almalki; Farqad Alamger; Ahmed Krimly; Wail Al Kashkari
Journal:  Cardiol Res       Date:  2016-09-05

2.  Quality of care in primary percutaneous coronary intervention for acute ST-segment -elevation myocardial infarction: Gulf RACE 2 experience.

Authors:  Abdulla Shehab; Khalid Al-Habib; Ahmed Hersi; Husam Al-Faleh; Alawi Alsheikh-Ali; Wael Almahmeed; Kadhim J Suleiman; Ahmed Al-Motarreb; Jassim Al Suwaidy; Nidal Asaad; Shukri AlSaid; Muhammad Hashim; Haitham Amin
Journal:  Ann Saudi Med       Date:  2014 Nov-Dec       Impact factor: 1.526
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.